Universal Health Services said that as of December 31, 2024, the carrying value of its debt was approximately $4.5 billion and the fair value was approximately $4.2 billion, with total debt as a percentage of total capitalization of approximately 40% as of December 31, 2023 (44%).

1. 01

   Universal Health Services said that as of December 31, 2024, the carrying value of its debt was approximately $4.5 billion and the fair value was approximately $4.2 billion, with total debt as a percentage of total capitalization of approximately 40% as of December 31, 2023 (44%).

2. 02

   The company said it is uncertain as to the ultimate financial exposure related to the Pavilion and Cumberland jury verdicts for the 2020 policy year. As of December 31, 2024, the company and its subsidiaries have aggregate insurance coverage of approximately $221 million remaining under commercial policies for matters applicable to that policy year, without reduction for any potential amounts related to the Pavilion and Cumberland matters.

3. 03

   Universal Health Services said it expects to finance all capital expenditures, acquisitions and dividends and potentially repurchase shares utilizing internally generated and additional funds. As of December 31, 2024, its revolving credit facility had $1.17 billion of available borrowing capacity.

4. 04

   The company said it manages the development of District Facilities pursuant to an agreement with the District of Columbia, with approximately $344 million of a total of approximately $439 million incurred as of December 31, 2024, all funded by the District. Following completion, it will lease and operate the facilities for 75 years and has committed to spend a minimum of approximately $75 million over 12 years.

Key figures

Fiscal year ended December 31, 2024

Revenue

$15.8B

Operating income

$1.7B

Net income

$1.1B

EPS

$16.82

Operating cash flow

$2.1B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.